Literature DB >> 1653067

Decreased GABAA receptor subunit mRNA concentrations following chronic lorazepam administration.

I Kang1, L G Miller.   

Abstract

Chronic benzodiazepine administration has been associated with alterations in binding and function at the GABAA receptor. To evaluate effects of chronic benzodiazepine exposure on messenger RNA (mRNA) concentrations for several GABAA receptor subunits, we treated mice with lorazepam, 2 mg kg-1 daily for 1-28 days and evaluated mRNAs for the alpha 1 and gamma 2 subunits by Northern hybridization. In cerebral cortex, concentrations of mRNA for the alpha 1 and gamma 2 subunits were unchanged from vehicle or control after 1-10 days of lorazepam. However, after 14 days of treatment mRNA concentrations for both subunits decreased to approximately 50% of control values and remained decreased at 28 days. In contrast, no significant alterations were observed for either subunit mRNA in hippocampus or cerebellum over the same time course. Alterations in mRNAs in cortex occur after the development of tolerance and receptor downregulation in this model.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1653067      PMCID: PMC1908383          DOI: 10.1111/j.1476-5381.1991.tb09781.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  8 in total

1.  Sequence and functional expression of the GABA A receptor shows a ligand-gated receptor super-family.

Authors:  P R Schofield; M G Darlison; N Fujita; D R Burt; F A Stephenson; H Rodriguez; L M Rhee; J Ramachandran; V Reale; T A Glencorse
Journal:  Nature       Date:  1987 Jul 16-22       Impact factor: 49.962

Review 2.  Dependence, tolerance, and addiction to benzodiazepines: clinical and pharmacokinetic considerations.

Authors:  D J Greenblatt; R I Shader
Journal:  Drug Metab Rev       Date:  1978       Impact factor: 4.518

3.  Autoradiographic localization of benzodiazepine receptor downregulation.

Authors:  E I Tietz; H C Rosenberg; T H Chiu
Journal:  J Pharmacol Exp Ther       Date:  1986-01       Impact factor: 4.030

4.  Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology.

Authors:  D B Pritchett; H Sontheimer; B D Shivers; S Ymer; H Kettenmann; P R Schofield; P H Seeburg
Journal:  Nature       Date:  1989-04-13       Impact factor: 49.962

5.  Chronic benzodiazepine administration. IV. Rapid development of tolerance and receptor downregulation associated with alprazolam administration.

Authors:  L G Miller; S Woolverton; D J Greenblatt; F Lopez; R B Roy; R I Shader
Journal:  Biochem Pharmacol       Date:  1989-11-01       Impact factor: 5.858

6.  Chronic diazepam treatment produces regionally specific changes in GABA-stimulated chloride influx.

Authors:  R J Marley; D W Gallager
Journal:  Eur J Pharmacol       Date:  1989-01-17       Impact factor: 4.432

7.  Chronic benzodiazepine administration. I. Tolerance is associated with benzodiazepine receptor downregulation and decreased gamma-aminobutyric acidA receptor function.

Authors:  L G Miller; D J Greenblatt; J G Barnhill; R I Shader
Journal:  J Pharmacol Exp Ther       Date:  1988-07       Impact factor: 4.030

8.  Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA.

Authors:  C Auffray; F Rougeon
Journal:  Eur J Biochem       Date:  1980-06
  8 in total
  20 in total

1.  Rate of change of blood concentrations is a major determinant of the pharmacodynamics of midazolam in rats.

Authors:  A Cleton; D Mazee; R A Voskuyl; M Danhof
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Glutamic acid decarboxylase and glutamate receptor changes during tolerance and dependence to benzodiazepines.

Authors:  E Izzo; J Auta; F Impagnatiello; C Pesold; A Guidotti; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

3.  Silent GABAA synapses during flurazepam withdrawal are region-specific in the hippocampal formation.

Authors:  P Poisbeau; S R Williams; I Mody
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

4.  Chronic benzodiazepine treatment does not alter interactions between positive GABA(A) modulators and flumazenil or pentylenetetrazole in monkeys.

Authors:  Lisa R Gerak; Charles P France
Journal:  Behav Pharmacol       Date:  2011-02       Impact factor: 2.293

Review 5.  Control of receptor sensitivity at the mRNA level.

Authors:  B J Morris
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

Review 6.  Measuring human brain GABA in vivo: effects of GABA-transaminase inhibition with vigabatrin.

Authors:  O A Petroff; D L Rothman
Journal:  Mol Neurobiol       Date:  1998-02       Impact factor: 5.590

7.  Plasticity in GABAA receptor subunit mRNA expression by hypothalamic magnocellular neurons in the adult rat.

Authors:  V S Fénelon; A E Herbison
Journal:  J Neurosci       Date:  1996-08-15       Impact factor: 6.167

8.  Benzodiazepine treatment induces subtype-specific changes in GABA(A) receptor trafficking and decreases synaptic inhibition.

Authors:  Tija C Jacob; Guido Michels; Liliya Silayeva; Julia Haydon; Francesca Succol; Stephen J Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

9.  Molecular mechanisms of benzodiazepine-induced down-regulation of GABAA receptor alpha 1 subunit protein in rat cerebellar granule cells.

Authors:  M J Brown; D R Bristow
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

10.  Chronic administration of the antidepressants phenelzine, desipramine, clomipramine, or maprotiline decreases binding to 5-hydroxytryptamine2A receptors without affecting benzodiazepine binding sites in rat brain.

Authors:  K G Todd; D J McManus; G B Baker
Journal:  Cell Mol Neurobiol       Date:  1995-06       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.